REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 135 filers reported holding REVOLUTION MEDICINES INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,689,361 | -26.3% | 97,159 | -28.8% | 0.00% | 0.0% |
| Q2 2023 | $3,650,145 | +21.8% | 136,454 | -1.4% | 0.00% | 0.0% |
| Q1 2023 | $2,996,899 | -25.0% | 138,361 | -17.5% | 0.00% | 0.0% |
| Q4 2022 | $3,993,256 | +519.1% | 167,643 | +412.6% | 0.00% | – |
| Q3 2022 | $645,000 | -19.4% | 32,703 | -20.3% | 0.00% | – |
| Q2 2022 | $800,000 | -65.2% | 41,032 | -54.5% | 0.00% | -100.0% |
| Q1 2022 | $2,300,000 | -20.1% | 90,149 | -21.2% | 0.00% | 0.0% |
| Q4 2021 | $2,879,000 | -10.8% | 114,420 | -2.5% | 0.00% | 0.0% |
| Q3 2021 | $3,228,000 | +9122.9% | 117,350 | +10587.6% | 0.00% | – |
| Q2 2021 | $35,000 | -47.0% | 1,098 | -23.6% | 0.00% | – |
| Q1 2021 | $66,000 | +37.5% | 1,438 | +19.5% | 0.00% | – |
| Q4 2020 | $48,000 | -68.8% | 1,203 | -75.4% | 0.00% | – |
| Q2 2020 | $154,000 | -15.8% | 4,892 | -41.6% | 0.00% | – |
| Q1 2020 | $183,000 | – | 8,371 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nextech Invest Ltd. | 4,839,529 | $133,958,163 | 40.59% |
| Column Group LLC | 1,230,641 | $34,064,143 | 22.62% |
| Boxer Capital, LLC | 4,684,264 | $129,660,428 | 6.90% |
| Finepoint Capital LP | 427,000 | $11,819,360 | 5.89% |
| Casdin Capital, LLC | 1,810,000 | $50,100,800 | 5.54% |
| EcoR1 Capital, LLC | 5,577,863 | $154,395,248 | 5.21% |
| DAFNA Capital Management LLC | 473,394 | $13,103,546 | 4.08% |
| Artal Group S.A. | 2,529,737 | $70,023 | 3.00% |
| BVF INC/IL | 3,981,212 | $110,199,948 | 2.97% |
| Bellevue Group AG | 4,721,500 | $130,691,120 | 2.11% |